Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inamed correction

This article was originally published in The Gray Sheet

Executive Summary

Inamed received an FDA "approvable" letter in September for the following breast implant models: Styles 10, 15, 20, 40, 45, 110, 115 and 120, after it removed Style 153 from the application (1"The Gray Sheet" Sept. 26, 2005, p. 17). An article in the Dec. 12 issue of "The Gray Sheet" incorrectly stated that Inamed had received an "approvable" letter for its Style 153 silicone breast implant (2"The Gray Sheet" Dec. 12, 2005, p. 8)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT023030

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel